{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cardiotoxicity", "cytotoxic", "erucic acid", "neuroprotective"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36838911", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "17"}], "Language": ["eng"], "ELocationID": ["1924", "10.3390/molecules28041924"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "17"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Erucic Acid-Both Sides of the Story: A Concise Review on Its Beneficial and Toxic Properties.", "Abstract": {"AbstractText": ["Erucic acid (EA) is monounsaturated fatty acid (22:1 n-9), synthesized in the seeds of many plants from the <i>Brassicaceae</i> family, with <i>Brassica napus</i>, <i>B. rapa</i>, or <i>B. carinata</i> considered as its richest source. As the compound has been blamed for the poisoning effect in Toxic Oil Syndrome, and some data indicated its cardiotoxicity to rats, EA has been for decades classified as toxic substance, the use of which should be avoided. However, the cardiac adverse effects of EA have not been confirmed in humans, and the experiments in animal models had many limitations. Thus, the aim of this review was to present the results of the so far published studies on both toxic, and pharmacological properties of EA, trying to answer the question on its future medicinal use. Despite the ambiguous and relatively small data on toxic and beneficial effects of EA it seems that the compound is worth investigating. Further research should be particularly directed at the verification EA toxicity, more in-depth studies on its neuroprotective and cytotoxic properties, but also its use in combination with other drugs, as well as its role as a drug carrier."]}, "AuthorList": [{"Identifier": ["0000-0001-5636-8646"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland."}], "LastName": "Galanty", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": ["0000-0001-9338-3677"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Chemistry and Nutrition, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland."}], "LastName": "Grudzi\u0144ska", "ForeName": "Marta", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland."}], "LastName": "Pa\u017adziora", "ForeName": "Wojciech", "Initials": "W"}, {"Identifier": ["0000-0002-4821-4492"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Chemistry and Nutrition, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland."}], "LastName": "Pa\u015bko", "ForeName": "Pawe\u0142", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "075441GMF2", "NameOfSubstance": "erucic acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Erucic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids, Monounsaturated"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Erucic Acids"}, {"QualifierName": [], "DescriptorName": "Fatty Acids, Monounsaturated"}, {"QualifierName": [], "DescriptorName": "Brassica napus"}, {"QualifierName": [], "DescriptorName": "Seeds"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Avato P., Argentieri M.P. Brassicaceae: A rich source of health improving phytochemicals. Phytochem. Rev. 2015;14:1019\u20131033. doi: 10.1007/s11101-015-9414-4.", "ArticleIdList": ["10.1007/s11101-015-9414-4"]}, {"Citation": "EFSA Panel on Contaminants in the Food Chain (CONTAM) Knutsen H.K., Alexander J., Barreg\u00e5rd L., Bignami M., Br\u00fcschweiler B., Ceccatelli S., Dinovi M., Edler L., Grasl-Kraupp B. Erucic acid in feed and food. EFSA J. 2016;14:e04593."}, {"Citation": "Heijkenskj\u00f6ld L., Ernster L. Studies of the mode of action of erucic acid on heart metabolism. Acta Med. Scand. 1975;198:75\u201383. doi: 10.1111/j.0954-6820.1975.tb06560.x.", "ArticleIdList": ["10.1111/j.0954-6820.1975.tb06560.x", "1062121"]}, {"Citation": "Sinclair H. Erucic acid and the Spanish oil epidemic. Lancet. 1981;318:1293. doi: 10.1016/S0140-6736(81)91533-6.", "ArticleIdList": ["10.1016/S0140-6736(81)91533-6", "6118706"]}, {"Citation": "Kilbourne E.M. Toxic-oil syndrome: Epidemic with an elusive etiology. Chest. 1985;88:324\u2013325. doi: 10.1378/chest.88.3.324.", "ArticleIdList": ["10.1378/chest.88.3.324", "4028841"]}, {"Citation": "Terracini B. Toxic Oil Syndrome: Ten Years of Progress. 1st ed. World Health Organization, Regional Office for Europe; Copenhagen, Denmark: 2004."}, {"Citation": "Fatouh M. Is Lorenzo\u2019s oil effective for the treatment of children with X-linked adrenoleukodystrophy? A systematic review of the literature. Arch. Dis. Child. 2022;107:A199\u2013A200."}, {"Citation": "Hulan H.W., Argentieri M.P., Mahadevan S., Sauer F.D., Corner A.H. Relationship between erucic acid and myocardial changes in male rats. Lipids. 1976;11:9\u201315. doi: 10.1007/BF02532578.", "ArticleIdList": ["10.1007/BF02532578", "1250074"]}, {"Citation": "Ishinaga M., Sato J., Kitagawa Y., Sugimoto E., Kito M. Perturbation of phospholipid metabolism by erucic acid in male Sprague-Dawley rat heart. J. Biochem. 1982;92:253\u2013263. doi: 10.1093/oxfordjournals.jbchem.a133921.", "ArticleIdList": ["10.1093/oxfordjournals.jbchem.a133921", "7118870"]}, {"Citation": "Murphy C.C., Murphy E.J., Golovko M.Y. Erucic acid is differentially taken up and metabolized in rat liver and heart. Lipids. 2008;43:391\u2013400. doi: 10.1007/s11745-008-3168-3.", "ArticleIdList": ["10.1007/s11745-008-3168-3", "18350328"]}, {"Citation": "De Wildt D.J., Speijers G.J.A. Influence of dietary rapeseed oil and erucic acid upon myocardial performance and hemodynamics in rats. Toxicol. Appl. Pharmacol. 1984;74:99\u2013108. doi: 10.1016/0041-008X(84)90275-8.", "ArticleIdList": ["10.1016/0041-008X(84)90275-8", "6729825"]}, {"Citation": "Bozcali E., S\u00fczer \u00d6., G\u00fcrsoy H.N., Atukeren P., G\u00fcm\u00fcstas K.M. Effects of erucic acid supplemented feeding on chronic doxorubucin toxicity in rats. Int. J. Clin. Exp. 2009;2:337.", "ArticleIdList": ["PMC2802050", "20057977"]}, {"Citation": "Altinoz M.A., Bilir A., Elmaci \u0130. Erucic acid, a component of Lorenzo\u2019s oil and PPAR-\u03b4 ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem. Biol. Interact. 2018;294:107\u2013117. doi: 10.1016/j.cbi.2018.08.024.", "ArticleIdList": ["10.1016/j.cbi.2018.08.024", "30142312"]}, {"Citation": "Bierenbaum M.L., Chen Y., Lei H., Watkins T. Relationship between dietary fatty acid, selenium, and degenerative cardiomyopathy. Med. Hypotheses. 1992;39:58\u201362. doi: 10.1016/0306-9877(92)90141-X.", "ArticleIdList": ["10.1016/0306-9877(92)90141-X", "1435394"]}, {"Citation": "Imamura F., Lemaitre R.N., King I.B., Song X., Steffen L.M., Folsom A.R., Mozaffarian D. Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts. Circulation. 2013;127:1512\u20131521. doi: 10.1161/CIRCULATIONAHA.112.001197.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.112.001197", "PMC3717970", "23487436"]}, {"Citation": "Kageyama K., Nagasawa T., Kimura S., Kobayashi T., Kinoshita Y. Cytotoxic activity of unsaturated fatty acids to lymphocytes. Can. J. Biochem. 1980;58:504\u2013508. doi: 10.1139/o80-068.", "ArticleIdList": ["10.1139/o80-068", "6168348"]}, {"Citation": "Christiansen E.N., Gray T.J., Lake B.G. Effect of very long chain fatty acids on peroxisomal \u03b2-oxidation in primary rat hepatocyte cultures. Lipids. 1985;20:929\u2013932. doi: 10.1007/BF02534779.", "ArticleIdList": ["10.1007/BF02534779", "4094523"]}, {"Citation": "Kawano H., Nishizawa-Tanaka Y., Yasuda S., Sakai D., Miyake M., Mayumi T., Hama T. Induction of peroxisomal \u03b2-oxidation and fatty acid content in primary cultures of rat hepatocytes. J. Clin. Biochem. Nutr. 1997;23:145\u2013153. doi: 10.3164/jcbn.23.145.", "ArticleIdList": ["10.3164/jcbn.23.145"]}, {"Citation": "El Bioukar B., Straehli F., Ng K.H., Rolland M.O., Hashimoto T., Carreau J.P., Deschatrette J. Resistance to erucic acid as a selectable marker for peroxisomal activity: Isolation of revertants of an infantile Refsum disease cell line. J. Inherit. Metab. Dis. 1994;17:41\u201359. doi: 10.1007/BF00735394.", "ArticleIdList": ["10.1007/BF00735394", "7519689"]}, {"Citation": "Takahashi A., Dohi H., Egashira Y., Hirai S. Erucic acid derived from rosemary regulates differentiation of mesenchymal stem cells into osteoblasts/adipocytes via suppression of peroxisome proliferator-activated receptor \u03b3 transcriptional activity. Phytother. Res. 2020;34:1358\u20131366. doi: 10.1002/ptr.6607.", "ArticleIdList": ["10.1002/ptr.6607", "31989712"]}, {"Citation": "Pl\u00f6tz T., von Hanstein A.S., Kr\u00fcmmel B., Laporte A., Mehmeti I., Lenzen S. Structure-toxicity relationships of saturated and unsaturated free fatty acids for elucidating the lipotoxic effects in human EndoC-\u03b2H1 beta-cells. Biochim. Biophys. Acta Mol. Basis Dis. 2019;1865:165525. doi: 10.1016/j.bbadis.2019.08.001.", "ArticleIdList": ["10.1016/j.bbadis.2019.08.001", "31398470"]}, {"Citation": "Goc A., Niedzwiecki A., Rath M. Anti-borreliae efficacy of selected organic oils and fatty acids. BMC Complement Altern. Med. 2019;19:1\u201311. doi: 10.1186/s12906-019-2450-7.", "ArticleIdList": ["10.1186/s12906-019-2450-7", "PMC6360722", "30717726"]}, {"Citation": "Chrzanowska A., Roszkowski P., Bielenica A., Olejarz W., St\u0119pie\u0144 K., Struga M. Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates. Eur. J. Med. Chem. 2020;185:111810. doi: 10.1016/j.ejmech.2019.111810.", "ArticleIdList": ["10.1016/j.ejmech.2019.111810", "31678743"]}, {"Citation": "Liang X., Huang Y., Pan X., Hao Y., Chen X., Jiang H., Yang Z. Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-\u03baB and p38 MAPK pathway. J. Pharm. Anal. 2020;10:130\u2013146. doi: 10.1016/j.jpha.2019.09.005.", "ArticleIdList": ["10.1016/j.jpha.2019.09.005", "PMC7192973", "32373385"]}, {"Citation": "Henry G.E., Momin R.A., Nair M.G., Dewitt D.L. Antioxidant and cyclooxygenase activities of fatty acids found in food. J. Agric. Food Chem. 2002;50:2231\u20132234. doi: 10.1021/jf0114381.", "ArticleIdList": ["10.1021/jf0114381", "11929276"]}, {"Citation": "Melzig M.F., Henke K. Inhibition of thrombin activity by selected natural products in comparison to neutrophil elastase. Planta Med. 2005;71:787\u2013789. doi: 10.1055/s-2005-871253.", "ArticleIdList": ["10.1055/s-2005-871253", "16142650"]}, {"Citation": "Aparna V., Dileep K.V., Sadasivan C., Haridas M. Computational and thermodynamic analyses of the phospholipase A2 inhibition by erucic acid and linoleic acid. Med. Chem. Res. 2013;22:1102\u20131106. doi: 10.1007/s00044-012-0114-y.", "ArticleIdList": ["10.1007/s00044-012-0114-y"]}, {"Citation": "Gan L., Feng L., Jiang W.D., Wu P., Liu Y., Jiang J., Zhou X.Q. Erucic acid impairs intestinal immune function of on-growing grass carp (Ctenopharyngodon idella) Aquaculture. 2020;519:734916. doi: 10.1016/j.aquaculture.2019.734916.", "ArticleIdList": ["10.1016/j.aquaculture.2019.734916"]}, {"Citation": "Hawkins R.A., Sangster K., Arends M.J. The apoptosis-inducing effects of polyunsaturated fatty acids (PUFAs) on benign and malignant breast cells in vitro. Breast. 1999;8:16\u201320. doi: 10.1016/S0960-9776(99)90332-6.", "ArticleIdList": ["10.1016/S0960-9776(99)90332-6"]}, {"Citation": "Erdlenbruch B., Jendrossek V., Gerriets A., Vetterlein F., Eibl H., Lakomek M. Erucylphosphocholine: Pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration. Cancer Chemother. Pharmacol. 1999;44:484\u2013490. doi: 10.1007/s002800051122.", "ArticleIdList": ["10.1007/s002800051122", "10550569"]}, {"Citation": "Chrzanowska A., Struga M., Roszkowski P., Koli\u0144ski M., Kmiecik S., Ja\u0142brzykowska K., Bielenica A. The effect of conjugation of ciprofloxacin and moxifloxacin with fatty acids on their antibacterial and anticancer activity. Int. J. Mol. Sci. 2022;23:6261. doi: 10.3390/ijms23116261.", "ArticleIdList": ["10.3390/ijms23116261", "PMC9181188", "35682940"]}, {"Citation": "Chrzanowska A., Olejarz W., Kubiak-Tomaszewska G., Ciechanowicz A.K., Struga M. The Effect of Fatty Acids on Ciprofloxacin Cytotoxic Activity in Prostate Cancer Cell Lines\u2014Does Lipid Component Enhance Anticancer Ciprofloxacin Potential? Cancers. 2022;14:409. doi: 10.3390/cancers14020409.", "ArticleIdList": ["10.3390/cancers14020409", "PMC8773529", "35053570"]}, {"Citation": "Kim E., Ko H.J., Jeon S.J., Lee S., Lee H.E., Kim H.N., Ryu J.H. The memory-enhancing effect of erucic acid on scopolamine-induced cognitive impairment in mice. Pharmacol. Biochem. Behav. 2016;142:85\u201390. doi: 10.1016/j.pbb.2016.01.006.", "ArticleIdList": ["10.1016/j.pbb.2016.01.006", "26780350"]}, {"Citation": "\u00dcnal \u0130., Cans\u0131z D., S\u00fcrmen M.G., S\u00fcrmen S., Sezer Z., Beler M., \u00dcst\u00fcndag \u00dc.V., G\u00fczel E., Alturfan A.A., Emekli-Alturfan E. Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPAR\u03b4-ligand erucic acid in rotenone-induced Parkinson\u2019s disease model in zebrafish. Eur. J. Neurosci. 2022;57:1\u201322. doi: 10.1111/ejn.15904.", "ArticleIdList": ["10.1111/ejn.15904", "36564343"]}, {"Citation": "Judy K.D., Olivi A., Buahin K.G., Domb A., Epstein J.I., Colvin O.M., Brem H. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J. Neurosurg. 1995;82:481\u2013486. doi: 10.3171/jns.1995.82.3.0481.", "ArticleIdList": ["10.3171/jns.1995.82.3.0481", "7861228"]}, {"Citation": "Olivi A., Ewend M.G., Utsuki T., Tyler B., Domb A.J., Brat D.J., Brem H. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemother. Pharmacol. 1996;39:90\u201396.", "ArticleIdList": ["8995504"]}, {"Citation": "Golenser J., Domb A., Teomim D., Tsafack A., Nisim O., Ponka P., Cabantchik Z.I. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release. J. Pharmacol. Exp. Ther. 1997;281:1127\u20131135.", "ArticleIdList": ["9190845"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "30"}, {"Year": "2023", "Month": "2", "Day": "14"}, {"Year": "2023", "Month": "2", "Day": "15"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "4", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["36838911", "PMC9962393", "10.3390/molecules28041924", "molecules28041924"]}}], "PubmedBookArticle": []}